Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant

Program Overview

Join experts, Fernanda P. Silveira, MD, MS, FIDSA, FAST and Jennifer Saullo, MD, PharmD, FIDSA, as they delve into the complexities of cytomegalovirus (CMV) prevention and treatment following solid organ transplantation (SOT). Presentations will feature detailed case discussions with a focus on managing resistant and refractory disease, addressing treatment-related toxicities, and optimizing therapeutic strategies. This program is an essential primer on the scientific challenges and solutions in this critical area of transplant medicine.

Credit Expired

Target Audience

Transplant specialists/surgeons, nephrologists, internal medicine, and infectious disease clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Employ antiviral treatments to prevent and manage cytomegalovirus (CMV) in solid organ transplant (SOT) patients
  • Create treatment strategies for refractory or resistant CMV in SOT patients that leverage recent advancements in antiviral therapy while minimizing side effects

Activity Faculty

Jennifer Saullo-Medicine-455px x 500px

Jennifer Saullo, MD, PharmD, FIDSA

Associate Professor, Department of Medicine
Division of Infectious Diseases
Transplant Infectious Diseases Service
Duke University Medical Center
Durham, NC

 

 

62-22-1045 CMV Faculty Headshot-SILVEIRA_FERNANDA

Fernanda P. Silveira, MD, MS, FIDSA, FAST

Professor, Medicine
Director, Clinical Operations
Transplant Infectious Diseases
University of Pittsburgh Medical Center
Pittsburgh, PA

 

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources